A fusion protein of IL-15-IL-15Ra and anti-FAP caused superior targeted anti-tumor killing ability, providing a rationale for the development of antibody-IL-15-IL-15Ra fusion proteins for cancer immunotherapy in the future [36]. The gene discussed is FAP; the disease is neoplasm.